Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran

Journal of Microbiology

Volumn 49, Issue 6, 2011, Pages 987-993

  Abadi, Amin Talebi Bezmin ^a   Taghvaei, Tarang ^b   Mobarez, Ashraf Mohabbati ^a   Carpenter, Beth M ^c   Merrell, Scott ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

amoxicillin; antibiotic resistance; Helicobacter; Iran; metronidazole; multidrug resistance

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG EFFECT; FEMALE; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IRAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; MALE; MIDDLE AGED; YOUNG ADULT;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 84555206978     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-011-1170-6     Document Type: Article

References (36)

1. Agudo, S., G. Perez-Perez, T. Alarcon, and M. Lopez-Brea. 2010. High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in madrid, Spain. J. Clin. Microbiol. 48, 3703-3707.
2. Blaser, M. J. 1990. Epidemiology and pathophysiology of Campylobacter pylori infections. Rev. Infect. Dis. 12Suppl 1, S99-106.
3. Block, B., G. Schachschal, and H. Schmidt. 2004. Endoscopy of the upper GI tract: A training manual, p. 194. Thieme, Mecical Publishers, Inc., New York, USA.
4. Boyanova, L. and I. Mitov. 2010. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev. Anti. Infect. Ther. 8, 59-70.
5. Boyanova, L., I. Stancheva, Z. Spassova, N. Katzarov, I. Mitov, and R. Koumanova. 2000. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. J. Med. Microbiol. 49, 415-418.
6. Dixon, M. F., R. M. Genta, J. H. Yardley, and P. Correa. 1996. Classification and grading of gastritis. The updated sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am. J. Surg. Pathol. 20, 1161-1181.
7. Dunn, B. E., H. Cohen, and M. J. Blaser. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10, 720-741.
8. Elviss, N. C., R. J. Owen, A. Breathnach, C. Palmer, and N. Shetty. 2005. Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000. J. Med. Microbiol. 54, 567-574.
9. Fakheri, H., R. Malekzadeh, S. Merat, M. Khatibian, A. Fazel, B. Z. Alizadeh, and S. Massarrat. 2001. Clarithromycin vs. Furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment. Pharmacol. Ther. 15, 411-416.
10. Farshad, S., A. Alborzi, A. Japoni, R. Ranjbar, K. Hosseini Asl, P. Badiee, M. Amin Shahidi, and M. Hosseini. 2010. Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, southern Iran. World J. Gastroenterol. 16, 5746-5751.
11. Gao, W., H. Cheng, F. Hu, J. Li, L. Wang, G. Yang, L. Xu, and X. Zheng. 2010. The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China. Helicobacter 15, 460-466.
12. Gisbert, J. P., X. Calvet, A. O'Connor, F. Megraud, and C. A. O'Morain. 2010. Sequential therapy for Helicobacter pylori eradication: A critical review. J. Clin. Gastroenterol. 44, 313-325.
13. Graham, D. Y. and L. Fischbach. 2010. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59, 1143-1153.
14. Horiki, N., F. Omata, M. Uemura, S. Suzuki, N. Ishii, Y. Iizuka, K. Fukuda, and et al. 2009. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter 14, 86-90.
15. Hulten, K., A. Gibreel, O. Skold, and L. Engstrand. 1997. Macrolide resistance in Helicobacter pylori: Mechanism and stability in strains from clarithromycin-treated patients. Antimicrob. Agents Chemother. 41, 2550-2553.
16. Jones, K. R., J. Cha, and D. S. Merrell. 2008. Who's winning the war? Molecular mechanisms of antibiotic resistance in Helicobacter pylori. Curr. Drug Ther. 3, 190-203.
17. Kohanteb, J., A. Bazargani, M. Saberi-Firoozi, and A. Mobasser. 2007. Antimicrobial susceptibility testing of Helicobacter pylori to selected agents by agar dilution method in shiraz-iran. Indian J. Med. Microbiol. 25, 374-377.
18. Leodolter, A., M. Kulig, H. Brasch, W. Meyer-Sabellek, S. N. Willich, and P. Malfertheiner. 2001. A meta-analysis comparing eradication, healing and relapse rates in patients with helicobacter pylori-associated gastric or duodenal ulcer. Aliment. Pharmacol. Ther. 15, 1949-1958.
19. Malekzadeh, R., R. Ansari, H. Vahedi, F. Siavoshi, B. Z. Alizadeh, M. R. Eshraghian, A. Vakili, M. Saghari, and S. Massarrat. 2000. Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease. Aliment. Pharmacol. Ther. 14, 299-303.
20. Malekzadeh, R., M. H. Derakhshan, and Z. Malekzadeh. 2009. Gastric cancer in Iran: Epidemiology and risk factors. Arch. Iran Med. 12, 576-583.
21. Malfertheiner, P., F. Megraud, C. O'Morain, F. Bazzoli, E. El-Omar, D. Graham, R. Hunt, T. Rokkas, N. Vakil, and E. J. Kuipers. 2007. Current concepts in the management of Helicobacter pylori infection: The maastricht iii consensus report. Gut 56, 772-781.
22. Marie, M. A. M. 2008. Patterns of Helicobacter pylori resistance to metronidazole, clarithromycin and amoxicillin in Saudi Arabia. J. Bacteriol. Virol. 38, 173-178.
23. Megraud, F. 2004. H. pylori antibiotic resistance: Prevalence, importance, and advances in testing. Gut 53, 1374-1384.
24. Megraud, F. and P. Lehours. 2007. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin. Microbiol. Rev. 20, 280-322.
25. Mohammadi, M., D. Doroud, N. Mohajerani, and S. Massarrat. 2005. Helicobacter pylori antibiotic resistance in Iran. World J. Gastroenterol. 11, 6009-6013.
26. O'Connor, A., J. P. Gisbert, D. McNamara, and C. O'Morain. 2010. Treatment of Helicobacter pylori infection 2010. Helicobacter 15Suppl 1, 46-52.
27. Osato, M. S., R. Reddy, S. G. Reddy, R. L. Penland, H. M. Malaty, and D. Y. Graham. 2001. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the united states. Arch. Intern. Med. 161, 1217-1220.
28. Riahizadeh, S., R. Malekzadeh, S. Agah, N. Zendehdel, R. Sotoudehmanesh, N. Ebrahimi-Dariani, A. Pourshams, and S. Massarrat. 2010. Sequential metronidazole-furazolidone or clarithromycin-furazolidone compared to clarithromycin-based quadruple regimens for the eradication of Helicobacter pylori in peptic ulcer disease: A double-blind randomized controlled trial. Helicobacter 15, 497-504.
29. Saberi-Firoozi, M. and M. Nejabat. 2006. Experiences with Helicobacter pylori treatment in Iran. Iran J. Med. Sci. 31, 181-185.
30. Segura, A. M., O. Gutierrez, W. Otero, A. Angel, R. M. Genta, and D. Y. Graham. 1997. Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection. Aliment. Pharmacol. Ther. 11, 529-532.
31. Siavoshi, F., F. Safari, D. Doratotaj, G. R. Khatami, G. H. Fallahi, and M. M. Mirnaseri. 2006. Antimicrobial resistance of Helicobacter pylori isolates from iranian adults and children. Arch. Iran Med. 9, 308-314.
32. Siavoshi, F., P. Saniee, S. Latifi-Navid, S. Massarrat, and A. Sheykholeslami. 2010. Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline-comparison of three 3-year studies. Arch. Iran Med. 13, 177-187.
33. Talebi Bezmin Adabi, A., A. Mohabati Mobarez, A. A. G. H. Ajami, R. Ali Reza, and T. Taghvaei. 2009. Evaluation on antibiotic resistance of Helicobacter pylori isolated from patients admitted to tooba medical center, Sari. J. Mazandaran Univ. Med. Sci. 19, 26-32.
34. Talebi Bezmin Abadi, A., A. M. Mobarez, T. Taghvaei, and L. Wolfram. 2010. Antibiotic resistance of Helicobacter pylori in mazandaran, north of iran. Helicobacter 15, 505-509.
35. Vakil, N. and F. Megraud. 2007. Eradication therapy for Helicobacter pylori. Gastroenterology 133, 985-1001.
36. Wolle, K., A. Leodolter, P. Malfertheiner, and W. Konig. 2002. Antibiotic susceptibility of Helicobacter pylori in Germany: Stable primary resistance from 1995 to 2000. J. Med. Microbiol. 51, 705-709.